Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$4.26k

Avg closing price
Price range

3 David Einhorn Adamis Pharmaceuticals Trades

David Einhorn started to build up the position in Adamis Pharmaceuticals in Q2 2021. Since then they sold 14.3k shares. The investor completely sold their stake between Q3 2021 and Q4 2021.

Avg closing price
Price range
Sold -4.18k shares Q4 2021
Avg closing price $4,365.98
Price range $2,809.66 - $6,027.00
Sold 70.8% shares (-10.1k shares) Q3 2021
Avg closing price $5,122.26
Price range $4,486.44 - $5,782.00
New holding (+14.3k shares) Q2 2021
Avg closing price $4,263.30
Price range $3,247.23 - $6,027.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!